SAVA Healthcare Limited

Startup
Summarized by Halo AI

SAVA Healthcare Limited is an Indian pharmaceutical company providing contract manufacturing and R&D services. They specialize in general and specialized formulations, including nasal sprays and dry powder inhalers for global markets.

Founded & HQ
Pune, Maharashtra, India
Company size
501-1,000 employees
Activity highlights
Successfully renewed its PIC/S-GMP certification for the fifth consecutive time from the State Service of Ukraine on Medicines and Drugs Control (SMDC) in August 2025.

SAVA Healthcare Limited is a pharmaceutical company that specializes in contract manufacturing and research and development. The company operates through several business verticals, including international pharmaceuticals, veterinary care, herbal solutions, and contract research and manufacturing services (CRAMS). Their manufacturing operations are centered in a WHO-GMP and PIC/s approved facility in Gujarat, which produces a variety of formulations such as tablets, capsules, ointments, creams, and specialized products like nasal sprays and dry powder inhalers. Their R&D activities are supported by a Department of Science and Industrial Research (DSIR) approved facility in Pune, where they focus on formulation development, analytical method validation, and stability studies to meet international regulatory standards.

The company serves as a strategic partner for pharmaceutical firms globally, offering expertise in product development, troubleshooting, and commercialization. By providing comprehensive support from initial formulation to large-scale production, SAVA Healthcare helps clients bring reliable and affordable generic pharmaceutical products to various international markets, including Asia, Africa, and CIS countries. Their consistent collaboration with established industry partners, combined with investments in advanced testing infrastructure such as Next Generation Impactors and spray pattern analyzers, ensures high-quality outcomes for their customer's diverse pharmaceutical portfolios.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

SP
Sriram Padmanabhan
Chief Scientific Officer
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.